Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shaughnessy

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
American Journal of Hematology|January 22, 2024
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myelomaXuehan Mao, Wenqiang Yan, David Mery, et al.
Cancer Biomarkers : Section a of Disease Markers|June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myelomaFumou Sun, Yan Cheng, Catherine Ma, et al.
Stem Cells (Dayton, Ohio)|July 7, 2011
Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in boneXin Li, Wen Ling, Angela Pennisi, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Blood Cancer Journal|October 16, 2025
Equal survival for Black Americans with multiple myeloma when appropriately matched to White AmericansDavid E Mery, Guido Tricot, Samer Al Hadidi, et al.
The Journal of Experimental Medicine|March 29, 2007
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathyRadek Spisek, Anjli Kukreja, Lin-Chi Chen, et al.
Blood|December 23, 2006
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomibGeorge Mulligan, Constantine Mitsiades, Barb Bryant, et al.
Blood|May 27, 2006
The molecular classification of multiple myelomaFenghuang Zhan, Yongsheng Huang, Simona Colla, et al.
Cancer Cell|April 18, 2006
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsDaniel R Carrasco, Giovanni Tonon, Yongsheng Huang, et al.
Blood Cancer Journal|February 14, 2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systemsWancheng Guo, Yihao Zhan, David Mery, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
American Journal of Hematology|January 22, 2024
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myelomaXuehan Mao, Wenqiang Yan, David Mery, et al.
Cancer Biomarkers : Section a of Disease Markers|June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myelomaFumou Sun, Yan Cheng, Catherine Ma, et al.
Stem Cells (Dayton, Ohio)|July 7, 2011
Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in boneXin Li, Wen Ling, Angela Pennisi, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Blood Cancer Journal|October 16, 2025
Equal survival for Black Americans with multiple myeloma when appropriately matched to White AmericansDavid E Mery, Guido Tricot, Samer Al Hadidi, et al.
The Journal of Experimental Medicine|March 29, 2007
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathyRadek Spisek, Anjli Kukreja, Lin-Chi Chen, et al.
Blood|December 23, 2006
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomibGeorge Mulligan, Constantine Mitsiades, Barb Bryant, et al.
Blood|May 27, 2006
The molecular classification of multiple myelomaFenghuang Zhan, Yongsheng Huang, Simona Colla, et al.
Cancer Cell|April 18, 2006
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsDaniel R Carrasco, Giovanni Tonon, Yongsheng Huang, et al.
Blood Cancer Journal|February 14, 2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systemsWancheng Guo, Yihao Zhan, David Mery, et al.
Pageof 20